J Dorey

568 total citations
37 papers, 319 citations indexed

About

J Dorey is a scholar working on Economics and Econometrics, Cellular and Molecular Neuroscience and General Health Professions. According to data from OpenAlex, J Dorey has authored 37 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 9 papers in Cellular and Molecular Neuroscience and 8 papers in General Health Professions. Recurrent topics in J Dorey's work include Genetic Neurodegenerative Diseases (9 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Economics and Policy (7 papers). J Dorey is often cited by papers focused on Genetic Neurodegenerative Diseases (9 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Economics and Policy (7 papers). J Dorey collaborates with scholars based in France, Japan and United States. J Dorey's co-authors include Mondher Toumi, Ayako Fukushima, C. Rémuzat, Samuel Aballéa, Hiroyuki Okumura, Tadao Akizawa, Lida Teng, Ataru Igarashi, E. Clay and Kazuhiko Arima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Joint Surgery and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

J Dorey

36 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Dorey France 10 78 66 47 47 37 37 319
Michael W. Pill United States 9 67 0.9× 38 0.6× 42 0.9× 55 1.2× 5 0.1× 10 531
Sheila R. Reddy United States 12 59 0.8× 10 0.2× 44 0.9× 60 1.3× 32 0.9× 32 381
Alexandra I. Barsdorf United States 11 24 0.3× 15 0.2× 75 1.6× 16 0.3× 15 0.4× 27 457
Mayank Ajmera United States 13 44 0.6× 13 0.2× 61 1.3× 10 0.2× 15 0.4× 41 399
Aaron Galaznik United States 13 32 0.4× 19 0.3× 31 0.7× 88 1.9× 8 0.2× 43 460
Tatyana Ionova Russia 10 16 0.2× 25 0.4× 19 0.4× 145 3.1× 7 0.2× 90 469
Alicia Ai-cia Cheak Singapore 8 12 0.2× 103 1.6× 26 0.6× 107 2.3× 4 0.1× 10 554
Knut Mueller Germany 7 19 0.2× 65 1.0× 12 0.3× 22 0.5× 13 0.4× 9 341
Philip Connor United Kingdom 11 9 0.1× 55 0.8× 20 0.4× 233 5.0× 9 0.2× 24 545
Hollie Schmidt United States 8 51 0.7× 95 1.4× 24 0.5× 25 0.5× 2 0.1× 20 413

Countries citing papers authored by J Dorey

Since Specialization
Citations

This map shows the geographic impact of J Dorey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Dorey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Dorey more than expected).

Fields of papers citing papers by J Dorey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Dorey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Dorey. The network helps show where J Dorey may publish in the future.

Co-authorship network of co-authors of J Dorey

This figure shows the co-authorship network connecting the top 25 collaborators of J Dorey. A scholar is included among the top collaborators of J Dorey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Dorey. J Dorey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toumi, Mondher, et al.. (2020). Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population. Frontiers in Medicine. 7. 323–323. 11 indexed citations
2.
Igarashi, Ataru, et al.. (2020). Family caregiving in dementia and its impact on quality of life and economic burden in Japan-web based survey. SHILAP Revista de lepidopterología. 8(1). 1720068–1720068. 28 indexed citations
3.
Fukushima, Ayako, et al.. (2018). Evolution of Hta System in Japan: Progress and Conservatism. Value in Health. 21. S46–S46. 1 indexed citations
4.
Auquier, Pascal, et al.. (2018). Cost Effective Only At A Zero Price: A Real-Time Scenario In Untreated Braf V600 Mutated Metastatic Melanoma?. Value in Health. 21. S46–S46. 1 indexed citations
5.
Fukushima, Ayako, et al.. (2018). 2018 Japan Drug Pricing System Radical Reform: Toward Enhancement of Drug Price Containment. Value in Health. 21. S46–S46. 1 indexed citations
6.
Akizawa, Tadao, et al.. (2017). Burden of Illness Associated With Anaemia In Chronic Kidney Disease In Japan: A Literature Review. Value in Health. 20(9). A492–A492. 2 indexed citations
7.
Hanna, Ehab Y., Jingna Zhou, J Dorey, et al.. (2016). Advanced Therapy Medicinal Products for Alzheimer's Disease Will Shrink the National Health Service Budget. Value in Health. 19(7). A523–A523. 2 indexed citations
8.
Hanna, Ehab Y., Fei Ma, Xurui Cheng, et al.. (2016). Future Innovative Therapies for Parkinson's Disease May Question Sustainability of Our Health Care System. Value in Health. 19(7). A438–A438. 1 indexed citations
9.
Hanna, Ehab Y., J Dorey, Samuel Aballéa, Pascal Auquier, & Mondher Toumi. (2016). Will Stem Cells For Heart Failure Be The Next Sofosbuvir Issue?. Value in Health. 19(7). A656–A656. 1 indexed citations
10.
11.
François, C., et al.. (2015). Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data. Journal of Medical Economics. 19(5). 515–525. 12 indexed citations
12.
Dorey, J, et al.. (2014). Impact of health insurance status on health care resource utilization among diabetic patients in the United States. Value in Health. 17(3). A252–A252. 1 indexed citations
13.
Luquiens, Amandine, Diane Whalley, Philippe Laramée, et al.. (2014). Development of the Alcohol Quality of Life Scale (AQoLS): a new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder. Quality of Life Research. 24(6). 1471–1481. 30 indexed citations
14.
Clay, E., A. Belhadj, Ferdinando Squitieri, et al.. (2014). Assessment Of The Huntington Quality Of Life Instrument (H-QOL-I) Cross-Cultural Validity. Value in Health. 17(7). A567–A567. 3 indexed citations
15.
Dorey, J, et al.. (2012). PIN77 Elicitation of Health-Related Quality of Life Concepts Associated With Cytomegalovirus in Transplant Recipients. Value in Health. 15(7). A399–A399. 3 indexed citations
16.
Clay, E., J Dorey, Ferdinando Squitieri, et al.. (2012). Validation of the first quality-of-life measurement for patients with Huntington’s disease. International Clinical Psychopharmacology. 27(4). 208–214. 14 indexed citations
17.
Aubeeluck, Aimée, J Dorey, Ferdinando Squitieri, et al.. (2012). Further evidence of reliability and validity of the Huntington’s disease quality of life battery for carers: Italian and French translations. Quality of Life Research. 22(5). 1093–1098. 9 indexed citations
18.
Dorey, J, et al.. (2012). M07 Burden of Huntington's disease in Spain. Journal of Neurology Neurosurgery & Psychiatry. 83(Suppl 1). A48.3–A48. 1 indexed citations
19.
20.
Dorey, J, Joakim Tedroff, Ferdinando Squitieri, et al.. (2011). PND38 International Comparison of Huntington Disease (HD) Burden. Value in Health. 14(7). A324–A324. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael W. Pill Breakdown of academic impact, for papers by Sheila R. Reddy Breakdown of academic impact, for papers by Alexandra I. Barsdorf Breakdown of academic impact, for papers by Mayank Ajmera Breakdown of academic impact, for papers by Aaron Galaznik Breakdown of academic impact, for papers by Tatyana Ionova Breakdown of academic impact, for papers by Alicia Ai-cia Cheak Breakdown of academic impact, for papers by Knut Mueller Breakdown of academic impact, for papers by Philip Connor Breakdown of academic impact, for papers by Hollie Schmidt
Rankless by CCL
2026